Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 09, 2026
TickeronGET DAILY SIGNALS
Rocket Lab (RKLB) Analyst Targets Point to +79% Upside – Execution Will Decide

Rocket Lab (RKLB) Analyst Targets Point to +79% Upside – Execution Will Decide

Key Takeaways

  • The central target of $105 is the arithmetic mean of roughly 20 verified, current analyst price targets for Rocket Lab USA, Inc. (RKLB), a NASDAQ-listed launch and space systems company.
  • Against the latest close near $58.80, reaching $105 would require a gain of roughly 79%, a very large move from current levels.
  • Individual targets span a wide range from approximately $60 to $150, reflecting sharp disagreement over valuation and the timing of the Neutron rocket program.
  • The strongest supports are rapid revenue growth, strong Electron demand, national-security contracts, and the planned Iridium acquisition.
  • The biggest risks are the Neutron launch delay into 2027, persistent losses, a premium valuation, and acquisition-related dilution.
  • Readers can explore more about this ticker's Major News, Today's Price Move, Forecast, and Earnings on dedicated pages.
  • For AI-driven market scanning across the broader market, explore Trending AI Robots.

Analyst Price Targets and the Consensus View

This stock carries ample analyst coverage, which makes the central target straightforward to derive. Reviewing roughly 20 current, individually attributed price targets from firms including Morgan Stanley ($105, Nov. 6, 2026), Cantor Fitzgerald ($122), Needham ($120), Deutsche Bank ($120), KeyBanc ($135), Stifel ($132), Roth MKM ($130), Bank of America ($110), Citigroup ($105), and Goldman Sachs ($67, Hold) produces an arithmetic mean of approximately $105. The full range runs from about $60 (Wells Fargo) up to $150 at the high end.

The average analyst rating is a consensus “Buy,” with a clear majority of Buy or Overweight ratings and only a handful of Holds. Cautious analysts, such as Goldman Sachs, point to valuation and execution risk, while bulls argue the market undervalues Rocket Lab’s vertically integrated launch and space-systems platform. Notably, several firms trimmed targets after the Neutron delay was announced, including Citizens JMP (to $90 from $130) and Goldman Sachs (to $67 from $75), whereas Morgan Stanley reiterated its $105 Buy on the view that the delay was a timing setback rather than a thesis change. I also checked this using Tickeron’s AI tools to see how sentiment lines up across similar growth names.

Current Market Position and the Path to the Target

At the most recent verified close near $58.80, the stock sits well below its 52-week high of roughly $151 reached in late May 2026, and above its 52-week low near $37.57. Reaching $105 implies an upside of about 79% — a very large move. The path would likely depend on demonstrating Neutron launch progress, converting the pending Iridium acquisition into accretive revenue, and moving toward positive free cash flow while sustaining the rapid top-line growth that has driven the stock’s historical re-rating.

Factors That Could Support a Move Toward the Target

Rocket Lab’s revenue continues to grow quickly. In its third quarter, revenue rose about 73% year-over-year to roughly $268 million, beating expectations, and management guided fourth-quarter revenue to between $270 million and $290 million. The Electron rocket has established commercial credibility, and the company is expanding into national-security and defense work. The planned Iridium acquisition would add a satellite-communications and services layer, which several analysts view as strengthening a diversified space platform and improving long-term cash-flow visibility.

Factors That Could Prevent the Target From Being Reached

The company is not yet profitable: third-quarter EPS missed estimates, and adjusted EBITDA remains negative. The first Neutron launch has slipped from late 2026 into 2027 after a defect was found in a first-stage tank component, delaying a key growth catalyst. The roughly $8 billion Iridium deal raises concerns about integration cost and shareholder dilution from newly issued equity. Finally, the stock trades at a premium valuation — investors have cited figures near 39 times enterprise value to sales — leaving limited room for error if growth or execution disappoints.

Technical Levels and Market Structure

RKLB trades far below its prior peak near $151, meaning the stock has given back a large portion of its 2026 rally. The 52-week low near $37.57 marks a meaningful support zone, while the prior highs in the $150 area represent long-term resistance. Round-number levels such as $100 and the analyst-heavy zone near $120–$135 could act as psychological and technical waypoints if the stock were to recover toward the central target.

Time Horizon and What Investors Should Monitor

Analyst price targets typically reflect a research horizon of roughly 12 months, though individual firms differ. Investors should monitor Neutron launch milestones and any revised timelines, the closing and integration of the Iridium acquisition, quarterly revenue growth and progress toward profitability, guidance updates, and analyst target revisions. Given the wide target range, shifts in sentiment around valuation and execution will matter as much as headline results. From what I see, tracking these catalysts alongside broader market signals helps clarify the setup.

Using AI Daily Buy/Sell Signals in Practice

Tickeron’s AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. I find these signals helpful for spotting shifts in momentum without having to screen manually every day, especially when following names like RKLB that move on both fundamental milestones and sentiment changes.

Final Assessment

Whether RKLB can reach $105 depends on execution as much as narrative. The target is a genuine analyst-derived average, but the $60-to-$150 range underscores how much the answer hinges on assumptions about Neutron, the Iridium integration, and the path to profitability. Rapid revenue growth and a strong competitive position in launch and space systems support the bullish case, while the launch delay, ongoing losses, a premium valuation, and dilution risk are the principal obstacles. The central target represents a very large move of about 79% from current levels and is best understood as an aggregate of widely varying analyst views rather than a guarantee. Investors should watch Neutron progress, Iridium closing details, and margin trends before drawing conclusions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RKLB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RKLB's RSI Oscillator recovers from oversold territory

The RSI Oscillator for RKLB moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In 30 of the 33 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 53 of 65 cases where RKLB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on RKLB as a result. In 77 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for RKLB just turned positive on November 09, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in 40 of 44 cases over the following month. The odds of a continued upward trend are 90%.

Following a +27.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in 265 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

RKLB moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

The Aroon Indicator for RKLB entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.717) is normal, around the industry mean (5.050). RKLB's P/E Ratio (-196.556) is considerably lower than the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (48.309) is also within normal values, averaging (18.367).

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 70 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKLB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 36.83B. The market cap for tickers in the group ranges from 4.49 to 1.77T. SPCX holds the highest valuation in this group at 1.77T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was 3%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -16%. FLY experienced the highest price growth at 49%, while DFNS experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was 34%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 55
Price Growth Rating: 64
SMR Rating: 78
Profit Risk Rating: 77
Seasonality Score: -18 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
CRWV stock surged +58% over the past 30 days, driven by major AI partnerships including a $21 billion expanded deal with Meta and multi-year agreements with Anthropic and Jane Street. Over the past quarter, shares rose +42%, reflecting analyst upgrades, strong revenue backlog growth to $66.8 billion, and sustained AI infrastructure demand.
IREN stock surged +56% over the past 30 days, driven primarily by the announcement of a $625 million acquisition of Mirantis to bolster AI cloud capabilities and the energization of its Sweetwater 1 data center. Over the past quarter, shares are up +31%, reflecting a recovery from earlier volatility tied to Q2 earnings miss and Bitcoin price fluctuations, fueled by the company's pivot to AI infrastructure.
Rocket Lab (RKLB) Analyst Targets Point to +79% Upside – Execution Will Decide